Astrana Health

ASTH

Market cap $1.02B

Astrana Health Inc. (NASDAQ: ASTH) stock on Tuesday fell around 22% to close at $21.48.

ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026.

The companies are projected to grow sales rapidly through 2027, and many of the stocks are expected to show double-digit increases this year.

Astrana Health, Inc. (ASTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ALHAMBRA, Calif., Jan. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P.

Astrana Health, Inc. ( ASTH ) Q3 2025 Earnings Call November 6, 2025 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call Participants Jailendra Singh - Truist Securities, Inc., Research Division Matthew Mardula - William Blair & Company L.L.C., Research Division Meghan Holtz - Jefferies LLC, Research Division Michael Ha Ryan Langston - TD Cowen, Research Division Thomas Walsh David Larsen - BTIG, LLC, Research Division Craig Jones - BofA Securities, Research Division Zachary Haggerty Eugene Mannheimer - Prime Executions, Inc., Research Division Presentation Operator Good day, everyone, and welcome to Astrana Health Third Quarter 2025 Earnings Call.

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago.

Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m.

ALHAMBRA, Calif. , Oct. 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2025, after the close of the stock market on Thursday, November 6, 2025.

These companies are expected to continue growing revenue at a rapid pace through 2027.